Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,364 USD | +4,96% | -1,17% | -12,50% |
Omzet 2024 * | 7,3 mln. 5,38 mln. 5 mln. | Omzet 2025 * | 9,12 mln. 6,73 mln. 6,25 mln. | Marktkapitalisatie | 2,98 mln. 2,2 mln. 2,04 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,41 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,33 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 13 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,64% |
Recentste transcriptie over InMed Pharmaceuticals Inc.
1 dag | +4,96% | ||
1 week | -1,17% | ||
Lopende maand | -12,29% | ||
1 maand | -13,33% | ||
3 maanden | -6,19% | ||
6 maanden | -47,25% | ||
Lopend jaar | -12,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Chief Operating Officer | - | 05-11-18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11-02-22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Andrew Hull
CHM | Chairman | 61 | 12-09-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 0,364 | +4,96% | 59 856 |
27-03-24 | 0,3468 | +0,49% | 62 624 |
26-03-24 | 0,3451 | -4,14% | 76 604 |
25-03-24 | 0,36 | -5,21% | 60 538 |
22-03-24 | 0,3798 | +3,12% | 64 220 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,50% | 2,2 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |